NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hercules Capital, Inc. ("Hercules" or "the Company") (NYSE:HTGC). Investors who purchased Hercules securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s […]

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or "the Company") (NASDAQ:CERE). Investors who purchased Cerevel securities prior to October 11, 2023, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Varonis Systems, Inc. ("Varonis" or "the Company") (NASDAQ:VRNS). Investors who purchased Varonis securities prior to February 4, 2025, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of IperionX Limited ("IperionX" or "the Company") (NASDAQ:IPX). Investors who purchased IperionX securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/IPX. IperionX

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ibotta, Inc. ("Ibotta" or "the Company") (NYSE:IBTA). Investors who purchased Ibotta securities prior to April 18, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV). Investors who purchased Elevance securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ELV.

AI-powered tactics are accelerating the scale, realism, and success of payment fraud attacks designed to bypass financial and security controls NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Trustmi, a leader in behavioral AI payment security, today released The Trustmi Payment Security & Risk Benchmark Report 2026, revealing that modern payment

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fiserv, Inc. ("Fiserv" or "the Company") (NYSE:FI). Investors who purchased Fiserv securities prior to July 24, 2024, and continue to hold to the present, are encouraged to obtain additional